Home / News

News

The most up to date reporting and breakthroughs in anal cancer and HPV research, and the HPV and Anal Cancer Foundation’s latest activities and events.

Filter By

First International Anal Cancer Screening Guidelines

First International Anal Cancer Screening Guidelines

Dear Friend, In a groundbreaking move towards global standardization in anal cancer screening, the International Anal Neoplasia Society (IANS) has released long-awaited comprehensive screening guidelines. Throughout the year, ACF actively participated on IANS’ screening guidelines committee, contributing to a pivotal moment in the journey to establish an international standard for anal cancer screening across diverse… read more

2023 Anal Cancer Patient Summit Speaker Bios

Kevin Du, M.D., PhD, MSCI Dr. Kevin Du joined Yale Cancer Center and Smilow Cancer Hospital from NYU Langone Health in NYC, where he was an Associate Professor of Radiation Oncology and Director of the Residency Program in Radiation Oncology. He received his medical degree from the University of Pennsylvania School of Medicine in 2006,… read more

Advocating for an HPV Cancer Awareness Campaign: The Anal Cancer Foundation Visits Capitol Hill

Advocating for an HPV Cancer Awareness Campaign: The Anal Cancer Foundation Visits Capitol Hill

The executive director of the Anal Cancer Foundation, Justine Almada, recently traveled to Washington, D.C. to meet with legislators on Capitol Hill. Her mission was clear: to advocate for an HPV Cancer Awareness Campaign and secure more funding for anal cancer and the other cancers caused by HPV. The Anal Cancer Foundation has been at… read more

2022 Year in Review

The Anal Cancer Foundation is starting yet another exciting year! With new partnerships forged and enlightening conversations with more experts in the anal cancer field, we feel as invigorated as ever for the new adventures 2023 will bring. If you missed it, please read about our advocacy push last month for the first national anal… read more

Thrivers Share Testimony with US Preventive Services Task Force

In January, the US Preventive Services Task Force (USPSTF) opened their draft research plan on anal cancer screening to public comment. This is the first time the Task Force has considered whether to recommend screening for anal cancer. Despite available treatments for precancer, anal cancer is not routinely screened for. Today, a correct and early… read more

2022 Virtual Patient Summit: 1 October

The 2022 Virtual Anal Cancer Patient Summit is an opportunity for anal cancer advocates, patients, and caregivers to learn, connect, and be empowered! Sessions will feature invited speakers: from oncologists to physical therapists, to thrivers who have faced anal cancer themselves. We look forward to bringing together the anal cancer community for a day dedicated… read more

Rare and Misunderstood: An IANS Annual Meeting Patient Panel

Rare and Misunderstood: An IANS Annual Meeting Patient Panel

On June 5th, the third day of the 2022 International Anal Neoplasia Society (IANS) Scientific Meeting in New York, a panel of brave and outspoken thrivers shared their experiences with the assembled medical experts, in a session entitled. “Rare and Misunderstood: Ten Years Later – Narratives and Perspective on the Anal Cancer Experience.” The session… read more

2022 International Anal Neoplasia Society Scientific Meeting

On June 3-5, researchers and medical professionals from all over the globe came together at the 2022 International Anal Neoplasia Society (IANS) Scientific Meeting In New York. They gathered to discuss best practices in anal cancer prevention and treatment, presenting their research and specific clinic experiences. Anal cancer and pre-cancer data were also shared by… read more

ANCHOR Trial Q & A

ANCHOR Trial Q & A

The groundbreaking ANCHOR study showed that early detection and treatment of anal HSIL (anal precancer) reduces cancer progression by 57%. Today, the study and results were published in the New England Journal of Medicine. The study was conceived by Anal Cancer Foundation scientific advisory board member Dr. Joel Palefsky, and supported through advocacy efforts by the… read more

A successful start to our 2022 Expert Hour webinar series!

A successful start to our 2022 Expert Hour webinar series!

We recently held the inaugural webinars in our 2022 Expert Hour webinar series: Clinical Trials 101 and Immunotherapy 101. Dr. Lee Rosen of the University of California, Los Angeles, and Dr. Julius Strauss of the National Institutes of Health were the first two experts to hold informative and insightful sessions. We were thrilled at the… read more